Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

PHASE3TerminatedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

December 25, 2007

Study Completion Date

December 25, 2007

Conditions
Lung Cancer
Interventions
DRUG

carboplatin

Given IV

DRUG

paclitaxel

Given IV

DRUG

paclitaxel poliglumex

Given IV

Trial Locations (41)

10451

Lincoln Medical and Mental Health Center, The Bronx

10595

New York Medical College, Valhalla

18015

Vita Hematology Oncology at St. Luke's Hospital, Bethlehem

24211

Cancer Outreach Associates - Abingdon, Abingdon

29615

Cancer Centers of the Carolinas - Eastside, Greenville

33021

Horizon Institute for Clinical Research, Hollywood

38077

Family Cancer Center, PLLC - Collierville, Collierville

38138

Mid-South Cancer Center, Germantown

39401

Hattiesburg Clinic, PA at Forrest General, Hattiesburg

44406

Blood and Cancer Center, Incorporated, Canfield

45219

Charles M. Barrett Cancer Center at University Hospital, Cincinnati

47150

Cancer Center of Indiana, New Albany

47591

Family Medicine of Vincennes Clinical Trial Center, Vincennes

47802

Providence Medical Group, Terre Haute

48275

Newland Medical Associates PC - Southfield, Southfield

49411

West Michigan Regional Cancer and Blood Center, Free Soil

58501

Mid Dakota Clinic, PC, Bismarck

60435

Joliet Oncology-Hematology Associates, Limited - West, Joliet

60461

Saint James Hospital and Health Centers Comprehensive Cancer Institute - Olympia Fields, Olympia Fields

60565

Hematology Oncology Consultants - Naperville, Naperville

60612

Rush Cancer Institute at Rush University Medical Center, Chicago

63110

Saint Louis University Cancer Center, St Louis

64131

Kansas City Cancer Centers - South, Kansas City

65201

Columbia Comprehensive Cancer Care Clinic, Columbia

73104

Oklahoma University Cancer Institute, Oklahoma City

75246

Mary Crowley Medical Research Center at Sammons Cancer Center, Dallas

78705

Southwest Regional Cancer Center - Central, Austin

78759

Lone Star Oncology - Austin, Austin

84403

Utah Hematology Oncology, PC, Ogden

85258

Scottsdale Medical Specialists, Scottsdale

89102

Las Vegas Cancer Center, Las Vegas

89520

Veterans Affairs Medical Center - Reno, Reno

90640

Clinical Trials and Research Associates, Incorporated, Montebello

91505

Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center, Burbank

98101

Virginia Mason Medical Center, Seattle

98119

Cell Therapeutics, Incorporated, Seattle

92025-4404

Southwest Cancer Care - Escondido, Escondido

94305-5824

Stanford Cancer Center, Stanford

33308-1414

Broward Oncology Associates, Fort Lauderdale

10310-1699

Richmond University Medical Center, Staten Island

44710-1799

Aultman Cancer Center at Aultman Hospital, Canton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CTI BioPharma

INDUSTRY

NCT00551733 - Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter